Colorectal cancer follow-up: useful or useless?

Surg Oncol. 2006 Jul;15(1):1-12. doi: 10.1016/j.suronc.2006.06.001. Epub 2006 Aug 7.

Abstract

Follow-up of surgically treated colorectal cancer patients is not supported by objectively certain data. Despite the thousands of investigations reported in the scientific literature, only six randomized prospective studies and two meta-analysis of randomized studies provide data suggesting clear conclusions. Our review of the literature revealed that intensive colorectal follow-up should be performed even if the long-term survival benefit is small. The timing and investigations conducted in follow-ups diverge. The inconsistency of follow-ups is revealed by the fact that the leading USA and European societies propose different guidelines. One datum that the literature agrees on is that pancolonoscopy performed at 3-5 year intervals in colorectal cancer surgery patients supports diagnosis of adenomatous polyps and metachronous cancers. Cost analysis have shown that intensive follow-up would certainly exceed the cut-off point level set for every additional year of good quality of life.

Publication types

  • Review

MeSH terms

  • Carcinoembryonic Antigen / metabolism
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / therapy*
  • Cost-Benefit Analysis
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Neoplasm Metastasis
  • Recurrence
  • Survival Analysis
  • Treatment Outcome

Substances

  • Carcinoembryonic Antigen